.jpg)
The Court stated that the accusations made against the accused are quite serious.
Prison
A man accused of producing and distributing fake Mounjaro KwikPen, a diabetes and weight-loss drug, was recently denied bail by a Gurugram court [Avi Sharma v State].
Additional Sessions Judge Yashwinder Paul Singh stated in a June 20 decision that the accusations made against Avi Sharma were grave.
The Court further stated that the evidence in the file indicated that he had sold counterfeit, adulterated, and mislabeled medications to deceive the public.The petitioner is facing very serious accusations. The Court noted that his actions seem to be selling phony, contaminated, and mislabeled medications and engaging in fraud with the general public.
In a lawsuit filed under several sections of the medications and Cosmetics Act, Sharma was detained on April 19 for allegedly manufacturing and selling medications without a license, trading in counterfeit drugs, and misrepresenting their maker or place of origin.
The Drugs Control Officer had previously been informed in confidence that a car close to Super Mart I in Gurugram was filled with fake Mounjaro KwikPen injections.
The car was then stopped by a squad of police and narcotics inspectors, who found injections that were purportedly labeled Mounjaro KwikPen. Mujammil Khan, one of the car's occupants, recognized Sharma as the owner of the recovered goods, according to the prosecution.
After being summoned to the location, Sharma allegedly acknowledged being the product's owner.Sharma, the petitioner, was unable to provide a legitimate license or the invoices for the importation of the medications in question. It was discovered that three of the drug's labels were fake. The labels of the aforementioned pharmaceuticals were found during a search of the petitioner's home, the court stated in the ruling.
The Court further stated that the seized injections were identified as Mounjaro KwikPen, a medication brought into India by Eli Lilly and Company (India) from Eli Lilly Italia SpA in Italy.
The prosecution claims that the seized injections had a maximum retail price of over ₹56.15 lakh and were not kept at the temperature specified on their labels.
The maker of the original Mounjaro injections was approached by investigators, the Court noted, and they purportedly verified that they had not produced the seized goods.
Additionally, it documented the accusation that Sharma was producing a different product named "Tone Up" while falsely stating on the label that it was made in Japan, even though it was purportedly made without a legitimate manufacturing license.
Sharma said in his bail request that he was no longer needed for the inquiry because he had been detained since April 19.
He argued that a co-accused's statement was the main basis for the case. Additionally, he claimed that no independent witness had been connected to the retrieval and that no drugs had been taken directly from his possession.
He added that his "Tone Up" project had never been offered for sale and was merely in the experimental stage.
Sharma was the main accused, according to the prosecution, and his release might impede the inquiry.
Avi Sharma (the accused) was represented by attorney Vipin Gupta.
Amandeep Chauhan, the State's Drugs Control Officer, made an in-person appearance.
